EDTUTC-4 New YorkLog in Sign up

DTCFF
DEFENCE THERAPEUTICS A
stockOTC

EODOct 2, 2026

0.2791USD+0.831%(+0.0023)11,581

Loading…

Loading…

12.71M

Healthcare

Biotechnology

HQ

Vancouver, BC, Canada

Previous Close

$0.28

Beta

-0.50

52-Week High

$0.78 2025-11-05

52-Week Low

$0.25 2026-07-22

SMA 50

$0.32

SMA 200

$0.43

Avg. Vol 10D

15,638

Avg. Vol 30D

10,056

Avg. Vol 90D

9,256

Relative Vol

1.15

45.54M

67.83M

6,119

Short Interest %

0.01%

1.00

1,624

1,624

1,624

Oct 1, 2026

03:15 AM EDTDefence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates ·

Newsfile

Sep 29, 2026

03:15 AM EDTDefence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors ·

Newsfile

Sep 28, 2026

05:00 PM EDTDefence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities ·

Newsfile

DTCFF Performance

Period	Price	Date	Change	Beta
1W	0.29	2026-09-28	-5.29%	4.403
1M	0.38	2026-09-04	-27.13%	2.207
3M	0.30	2026-07-02	-7.49%	0.687
6M	0.41	2026-04-06	-31.09%	-0.484
1Y	0.39	2025-10-02	-28.82%	-0.502
2Y	0.41	2024-09-23	-31.93%	—
5Y	5.37	2021-10-05	-94.80%	-0.296

DTCFF Stock Summary

DEFENCE THERAPEUTICS A (OTC:DTCFF) stock price today is $0.28, and today's volume is 11,581. DTCFF is up 0.831% today. The 30 day average volume is 10,056. DTCFF market cap is $12.71M with 45.54M shares outstanding.